- Home
- TORO vs MDCX Comparison
TORO vs MDCX Comparison
Compare TORO & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- MDCX
- Stock Information
- Founded
- TORO 2022
- MDCX 2008
- Country
- TORO Cyprus
- MDCX Canada
- Employees
- TORO N/A
- MDCX N/A
- Industry
- TORO Marine Transportation
- MDCX
- Sector
- TORO Consumer Discretionary
- MDCX
- Exchange
- TORO Nasdaq
- MDCX Nasdaq
- Market Cap
- TORO 36.7M
- MDCX 44.0M
- IPO Year
- TORO N/A
- MDCX N/A
- Fundamental
- Price
- TORO $2.93
- MDCX $3.10
- Analyst Decision
- TORO
- MDCX Strong Buy
- Analyst Count
- TORO 0
- MDCX 2
- Target Price
- TORO N/A
- MDCX $23.50
- AVG Volume (30 Days)
- TORO 752.9K
- MDCX 482.2K
- Earning Date
- TORO 08-11-2025
- MDCX 08-22-2025
- Dividend Yield
- TORO N/A
- MDCX N/A
- EPS Growth
- TORO N/A
- MDCX N/A
- EPS
- TORO 1.09
- MDCX N/A
- Revenue
- TORO $22,394,283.00
- MDCX N/A
- Revenue This Year
- TORO N/A
- MDCX N/A
- Revenue Next Year
- TORO N/A
- MDCX N/A
- P/E Ratio
- TORO $2.78
- MDCX N/A
- Revenue Growth
- TORO 0.40
- MDCX N/A
- 52 Week Low
- TORO $1.70
- MDCX $1.80
- 52 Week High
- TORO $4.05
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- TORO 75.13
- MDCX N/A
- Support Level
- TORO $2.12
- MDCX N/A
- Resistance Level
- TORO $2.29
- MDCX N/A
- Average True Range (ATR)
- TORO 0.20
- MDCX 0.00
- MACD
- TORO 0.05
- MDCX 0.00
- Stochastic Oscillator
- TORO 71.13
- MDCX 0.00
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.